338 related articles for article (PubMed ID: 16865281)
21. Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer.
Wauters E; Sanchez-Arévalo Lobo VJ; Pinho AV; Mawson A; Herranz D; Wu J; Cowley MJ; Colvin EK; Njicop EN; Sutherland RL; Liu T; Serrano M; Bouwens L; Real FX; Biankin AV; Rooman I
Cancer Res; 2013 Apr; 73(7):2357-67. PubMed ID: 23370328
[TBL] [Abstract][Full Text] [Related]
22. Telomerase gene expression in intraductal papillary-mucinous tumors (IPMT): preliminary findings.
Nodari F; Baiocchi GL; Salvi A; De Petro G; Coniglio A; Ferrari Bravo A; Baronchelli C; Barlati S; Giulini SM
Acta Biomed; 2003; 74 Suppl 2():59-64. PubMed ID: 15055037
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of ADAM 9 and ADAM 15 mRNA in pancreatic cancer.
Yamada D; Ohuchida K; Mizumoto K; Ohhashi S; Yu J; Egami T; Fujita H; Nagai E; Tanaka M
Anticancer Res; 2007; 27(2):793-9. PubMed ID: 17465204
[TBL] [Abstract][Full Text] [Related]
24. Heparanase expression in primary and metastatic pancreatic cancer.
Koliopanos A; Friess H; Kleeff J; Shi X; Liao Q; Pecker I; Vlodavsky I; Zimmermann A; Büchler MW
Cancer Res; 2001 Jun; 61(12):4655-9. PubMed ID: 11406531
[TBL] [Abstract][Full Text] [Related]
25. Study of the expression of the gene encoding Ki-67 antigen in human pancreatic cancer using non-radioactive in situ hybridization and immunohistochemistry.
Wu Y; Peng S; Sheng H
Chin Med J (Engl); 1997 Nov; 110(11):869-74. PubMed ID: 9772421
[TBL] [Abstract][Full Text] [Related]
26. Molecular genetics of intraductal papillary-mucinous neoplasms of the pancreas.
Furukawa T
J Hepatobiliary Pancreat Surg; 2007; 14(3):233-7. PubMed ID: 17520197
[TBL] [Abstract][Full Text] [Related]
27. CEACAM1, a novel serum biomarker for pancreatic cancer.
Simeone DM; Ji B; Banerjee M; Arumugam T; Li D; Anderson MA; Bamberger AM; Greenson J; Brand RE; Ramachandran V; Logsdon CD
Pancreas; 2007 May; 34(4):436-43. PubMed ID: 17446843
[TBL] [Abstract][Full Text] [Related]
28. [Claudin expression in different pancreatic cancers and its significance in differential diagnostics].
Borka K
Magy Onkol; 2009 Sep; 53(3):273-8. PubMed ID: 19793693
[TBL] [Abstract][Full Text] [Related]
29. High histone deacetylase 7 (HDAC7) expression is significantly associated with adenocarcinomas of the pancreas.
Ouaïssi M; Sielezneff I; Silvestre R; Sastre B; Bernard JP; Lafontaine JS; Payan MJ; Dahan L; Pirrò N; Seitz JF; Mas E; Lombardo D; Ouaissi A
Ann Surg Oncol; 2008 Aug; 15(8):2318-28. PubMed ID: 18506539
[TBL] [Abstract][Full Text] [Related]
30. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
31. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).
Argani P; Iacobuzio-Donahue C; Ryu B; Rosty C; Goggins M; Wilentz RE; Murugesan SR; Leach SD; Jaffee E; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Clin Cancer Res; 2001 Dec; 7(12):3862-8. PubMed ID: 11751476
[TBL] [Abstract][Full Text] [Related]
32. In situ telomerase activity in pancreatic juice may discriminate pancreatic cancer from other pancreatic diseases.
Uehara H; Nakaizumi A; Iishi H; Takenaka A; Eguchi H; Ohigashi H; Ishikawa O
Pancreas; 2008 Apr; 36(3):236-40. PubMed ID: 18362835
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma.
Cavallari I; Silic-Benussi M; Rende F; Martines A; Fogar P; Basso D; Vella MD; Pedrazzoli S; Herman JG; Chieco-Bianchi L; Esposito G; Ciminale V; D'Agostino DM
Genes Chromosomes Cancer; 2009 May; 48(5):383-96. PubMed ID: 19170121
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of human telomerase reverse transcriptase in pancreatic juice as a biomarker of pancreatic malignancy.
Nakashima A; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Oda M; Sueda T; Hiyama E
Pancreas; 2009 Jul; 38(5):527-33. PubMed ID: 19342980
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic changes of pituitary tumor-derived transforming gene 1 in pancreatic cancer.
Zhang ML; Lu S; Zheng SS
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):313-7. PubMed ID: 18522889
[TBL] [Abstract][Full Text] [Related]
36. [Expression of KiSS-1mRNA in pancreatic ductal adenocarcinoma and non-cancerous pancreatic tissues in SD rats].
Liang S; Yang ZL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):109-13. PubMed ID: 17344598
[TBL] [Abstract][Full Text] [Related]
37. S100P is an early developmental marker of pancreatic carcinogenesis.
Ohuchida K; Mizumoto K; Egami T; Yamaguchi H; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Clin Cancer Res; 2006 Sep; 12(18):5411-6. PubMed ID: 17000674
[TBL] [Abstract][Full Text] [Related]
38. Identification of molecular markers specific for pancreatic neuroendocrine tumors by genetic profiling of core biopsies.
Bloomston M; Durkin A; Yang I; Rojiani M; Rosemurgy AS; Enkmann S; Yeatman TJ; Zervos EE
Ann Surg Oncol; 2004 Apr; 11(4):413-9. PubMed ID: 15070602
[TBL] [Abstract][Full Text] [Related]
39. [A study of the gene encoding Ki-67 antigen in human pancreatic cancer using non-radioactive in situ hybridization and immunohistochemistry].
Wu Y; Peng S; Sheng H
Zhonghua Wai Ke Za Zhi; 1998 Dec; 36(12):732-4, 150. PubMed ID: 11825510
[TBL] [Abstract][Full Text] [Related]
40. Quantitative analysis of human telomerase reverse transcriptase in pancreatic cancer.
Ohuchida K; Mizumoto K; Yamada D; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2066-9. PubMed ID: 16609017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
